What You Should Know
- Medical technology firm SoundHealth has closed an oversubscribed Series A round led by Shangbay Capital, bringing its total venture funding to $12.25M.
- Flagship FDA-cleared wearable device, Sonu, has delivered over 500,000 acoustic resonance treatment sessions for patients ages 12+, becoming a leading non-drug alternative to corticosteroid nasal sprays for allergic and non-allergic rhinitis.
- Leverages smartphone facial scanning algorithms to construct custom digital sinus maps and calculate personalized acoustic resonant frequencies.
- Extends its anatomical dataset into the sleep technology sector with Spatial Sleep, a personalized acoustic wellness device designed to accelerate sleep onset and duration.
- Recommended by over 1,000 medical and dental professionals nationwide to treat population-scale breathing and sleep disorders without pharmaceutical side effects.
Craniofacial Mapping and Acoustic Resonant Frequency Tuning
The otolaryngology, sleep medicine, and consumer medical technology sectors face a persistent therapeutic challenge: reliance on long-term pharmaceutical interventions.
Millions of patients suffering from allergic and non-allergic rhinitis, sinus congestion, and sleep architecture disruption rely on over-the-counter or prescription steroid sprays, oral decongestants, and sedative sleep aids. However, extended pharmacological use frequently brings rebound congestion (rhinitis medicamentosa), systemic side effects, habituation, and high long-term prescription costs.
Despite these downsides, non-invasive, drug-free alternatives historically lacked the clinical rigor, personalized precision, and objective bio-acoustic data required for widespread physician adoption. To replace chronic drug dependencies with targeted, non-invasive bioelectric energy, SoundHealth’s platform merges AI computer vision with acoustic vibrational resonance to deliver drug-free therapeutic relief:
- Computer Vision Craniofacial Scanner: Utilizing a smartphone camera scan, SoundHealth’s proprietary algorithms construct a 3D digital model of a user’s unique sinus and facial bone structure.
- Resonant Frequency Calculation: Computes the exact vibrational frequencies required to induce optimal acoustic resonance within the individual’s sinus cavities.
- Targeted Acoustic Wave Delivery: The wearable Sonu band delivers gentle, calculated vibrational waves that stimulate autonomic nerve pathways and increase nitric oxide release in the nasal mucosa, reducing tissue swelling and congestion.
- Spatial Sleep Extension: Translates craniofacial resonance algorithms into sleep health, delivering personalized acoustic signals that facilitate faster sleep onset and deeper sleep continuity.
“Shangbay’s deep expertise in scaling medtech companies will benefit our growth trajectory,” stated Dr. Paramesh Gopi, CEO of SoundHealth. Co-Founder Dr. Bryant Lin added: “We are thrilled to have them as our Series A lead investor.”
